Already a DIA Member? Sign in. Not a member? Join.

Sign in

Forgot User ID? or Forgot Password?

Not a Member?

Create Account and Join

Sheraton Philadelphia University City

Oct 23, 2017 7:30 AM - Oct 26, 2017 5:00 PM

3549 Chestnut Street, Philadelphia, PA 19104

Regulatory Affairs: The IND, NDA, and Postmarketing

Session 25: Regulatory Compliance and FDA Inspections: What To Expect After Submitting the NDA

Session Chair(s)

Michael  Hamrell, PhD, RAC

Michael Hamrell, PhD, RAC

President

MORIAH Consultants, United States

  • GLP Inspections
  • GCP Inspections
  • Inspection Outcomes: Additional Considerations in GCP Inspections
  • GMP Inspections
  • Inspection Outcomes (GLPs, GCPs, GMPs)
  • FDA Enforcement Actions
  • Application Integrity Policy (AIP)

Have an account?

Be informed and stay engaged.

Don't miss an opportunity - join our mailing list to stay up to date on DIA insights and events.